Ritalin / Methylphenidate

Ritalin - Concerta - Equasym - Medikinet - Xenidate 

please click on each drug name above to connect to UK drug data sheets

Active Substance - Methylphenidate

FDA patient information data

Indication - Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

The United States drug regulator, the FDA has identified two possible safety concerns with the methylphenidate drug products: psychiatric adverse events and cardiovascular adverse events -

Statement on Concerta and Methylphenidate for the FDA Pediatric Advisory Committee - June 30, 2005

Reporting adverse side effects
There may be other side effects not on the data sheets.

 Please submit a Yellow Card report to the regulator (MHRA) in the UK or to the medicines regulator in your own country. The US FDA accept reports from any country.

The independent www.rxisk.org  web site also accept worldwide reports and provide additional information based on FDA statistics.

Be aware of interactions with other medicines..

Reporting Adverse Drug Reactions (ADRs)
If you have suffered psychiatric adverse reactions please report them. There may be side effects not mentioned on the data sheets. You can request a list of drugs used pre surgery and during surgery. You should be given patient information for all drugs prescribed as you are discharged from hospital.

Please report Adverse Drug Reactions (ADRs) to:

UK Yellow Card Reporting for Patient and Health Professional reports of Adverse Drug Reactions

USA and worldwide to the Food and Drug Administration for Patients and Healthcare Professionals

Universal free, independent drug safety website - Rxisk

Please follow APRIL on Twitter    For latest news read the APRIL blog

 

 

AWARENESS SAVES LIVES